These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30367664)

  • 41. The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye.
    Raji B; Dansault A; Leemput J; de la Houssaye G; Vieira V; Kobetz A; Arbogast L; Masson C; Menasche M; Abitbol M
    Mol Vis; 2007 Aug; 13():1412-27. PubMed ID: 17768378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease.
    Navarrete LP; Guzmán L; San Martín A; Astudillo-Saavedra L; Maccioni RB
    J Alzheimers Dis; 2012; 29(1):79-88. PubMed ID: 22232002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Piñero DJ; Hu J; Connor JR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
    Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
    Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
    Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
    ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
    López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
    Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical analysis of Musashi-1 expression during retinal regeneration of adult newt.
    Kaneko J; Chiba C
    Neurosci Lett; 2009 Feb; 450(3):252-7. PubMed ID: 19028551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A role for the ELAV RNA-binding proteins in neural stem cells: stabilization of Msi1 mRNA.
    Ratti A; Fallini C; Cova L; Fantozzi R; Calzarossa C; Zennaro E; Pascale A; Quattrone A; Silani V
    J Cell Sci; 2006 Apr; 119(Pt 7):1442-52. PubMed ID: 16554442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet.
    Gratuze M; Julien J; Morin F; Marette A; Planel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):452-461. PubMed ID: 28779908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.
    Chen HY; Wang ML; Laurent B; Hsu CH; Chen MT; Lin LT; Shen J; Chang WC; Hsu J; Hung MC; Chen YW; Huang PI; Yang YP; Li CP; Ma HI; Chen CH; Lin WC; Chiou SH
    Theranostics; 2020; 10(1):201-217. PubMed ID: 31903115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
    Ueberham U; Rohn S; Ueberham E; Wodischeck S; Hilbrich I; Holzer M; Brückner MK; Gruschka H; Arendt T
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):815-32. PubMed ID: 24964035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of Pin1 in the development of Alzheimer's disease.
    Wang S; Simon BP; Bennett DA; Schneider JA; Malter JS; Wang DS
    J Alzheimers Dis; 2007 Mar; 11(1):13-23. PubMed ID: 17361031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.
    Abreha MH; Dammer EB; Ping L; Zhang T; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Proteomics; 2018 Oct; 18(20):e1800108. PubMed ID: 30230243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.